Pelvic pain in transgender men taking testosterone: Assessing the risk of ovarian cancer

Miles Harris, Lauren Kondel, Caroline Dorsen

Research output: Contribution to journalArticle

Abstract

Some guidelines on care for transgender men taking testosterone recommend oophorectomy to prevent ovarian cancer, while others recommend following guidelines for females. A review of the literature finds no strong evidence that transgender men are at increased risk for ovarian cancer. In transgender men taking testosterone without other risk factors, oophorectomy to prevent cancer is unnecessary.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalNurse Practitioner
Volume42
Issue number7
DOIs
StatePublished - Jul 15 2017

Keywords

  • oophorectomy
  • ovarian cancer
  • pelvic pain
  • testosterone therapy
  • transgender men

ASJC Scopus subject areas

  • Nursing(all)

Fingerprint Dive into the research topics of 'Pelvic pain in transgender men taking testosterone: Assessing the risk of ovarian cancer'. Together they form a unique fingerprint.

  • Cite this